Loading...
Vor Biopharma Inc.
VOR•NASDAQ
Healthcare
Biotechnology
$0.21
$-0.02(-6.99%)
Vor Biopharma Inc. (VOR) Financial Performance & Statements
Review Vor Biopharma Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
3.85%
↑ 3.85%
Net Income Growth
0.81%
↑ 0.81%
Operating Cash Flow Growth
0.63%
↑ 0.63%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-142.13%
↓ 142.13%
ROIC
-131.93%
↓ 131.93%
Vor Biopharma Inc. (VOR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Vor Biopharma Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $900000.00 | $943000.00 |
| Gross Profit | $0.00 | $0.00 | -$900000.00 | -$943000.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $25.35M | $21.82M | $21.82M | $24.32M |
| SG&A Expenses | $5.96M | $6.70M | $6.31M | $7.06M |
| Operating Expenses | $31.31M | $28.51M | $28.14M | $31.38M |
| Total Costs & Expenses | $31.31M | $28.51M | $29.04M | $32.33M |
| Interest Income | $599000.00 | $954000.00 | $1.20M | $1.52M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $865000.00 | $851000.00 | $900000.00 | $943000.00 |
| EBITDA | -$30.45M | -$27.66M | -$29.04M | -$31.38M |
| EBITDA Ratio | ||||
| Operating Income | -$31.31M | -$28.51M | -$29.04M | -$32.33M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $599000.00 | $954000.00 | $1.20M | $1.52M |
| Income Before Tax | -$30.71M | -$27.56M | -$27.84M | -$30.80M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $899724.00 |
| Net Income | -$30.71M | -$27.56M | -$27.84M | -$30.80M |
| Net Income Ratio | ||||
| EPS | -$0.45 | -$0.40 | -$0.41 | -$0.45 |
| Diluted EPS | -$0.45 | -$0.40 | -$0.41 | -$0.45 |
| Weighted Avg Shares Outstanding | $69.97M | $68.47M | $68.30M | $68.03M |
| Weighted Avg Shares Outstanding (Diluted) | $69.97M | $68.47M | $68.30M | $68.03M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan